# Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis

> **NCT05647096** · NA · NOT_YET_RECRUITING · sponsor: **Santersus AG** · enrollment: 73 (estimated)

## Conditions studied

- Sepsis
- Respiratory Failure

## Interventions

- **DEVICE:** NucleoCapture device

## Key facts

- **NCT ID:** NCT05647096
- **Lead sponsor:** Santersus AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-05-05
- **Final completion:** 2027-05-28
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647096, "Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05647096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*